Ropinirole Kern Pharma 8 mg prolonged-release tablets EFG

Package leaflet: Information for the user

Introduction

Package leaflet: Information for the user

Ropinirol Kern Pharma 8 mg prolonged-release tablets EFG

Read all of this leaflet carefully before you start taking this medicine, because it contains important information for you.

• Keep this leaflet, as you may need to read it again.
• If you have any questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only, and you should not give it to other people, even if they have the same symptoms as you, because it could harm them.
• If you experience any adverse effects, consult your doctor or pharmacist, even if they are adverse effects not listed in this leaflet. See section 4.

Leaflet contents:

1. What Ropinirol Kern Pharma is and what it is used for
2. What you need to know before taking Ropinirol Kern Pharma
3. How to take Ropinirol Kern Pharma
4. Possible side effects
5. How to store Ropinirol Kern Pharma
6. Contents of the pack and other information

1. What is Ropinirol Kern Pharma and what is it used for?

The active substance in Ropinirol Kern Pharma is ropinirole, which belongs to a group of medicines called dopamine agonists. Dopamine agonists work in a similar way to a natural substance found in the brain, called dopamine.

Ropinirol Kern Pharma prolonged-release tablets are used for the treatment of Parkinson's disease.

People with Parkinson's disease have low levels of dopamine in certain parts of the brain. Ropinirole has an effect similar to natural dopamine and thereby reduces the symptoms of Parkinson's disease.

2. What you need to know before starting Ropinirol Kern Pharma

Do not take Ropinirol Kern Pharma

• if you are allergic to ropinirol or to any of the other components of Ropinirol Kern Pharma,
• if you have severe kidney disease,
• if you have liver disease.

Inform your doctor if you think you are in any of these situations.

Warnings and precautions

Talk to your doctor or pharmacist before starting to take Ropinirol Kern Pharma:

• if you are pregnant or think you might be pregnant,
• if you are breastfeeding,
• if you are under 18 years of age,
• if you have a serious heart condition,
• if you have a severe mental disorder,
• if you experience impulsive behavior and/or abnormal behavior (such as an overwhelming urge to gamble or excessive sexual behavior),
• if you have an intolerance to certain sugars (e.g., lactose).

Inform your doctor if you think you are in any of these situations. Your doctor will decide whether treatment with Ropinirol Kern Pharma is suitable for you, or if you need additional monitoring while taking it.

Inform your doctor if you notice symptoms such as depression, apathy, anxiety, fatigue, sweating, or pain when stopping or reducing treatment with Ropinirol (called dopamine agonist withdrawal syndrome or DAWS). If these problems persist for several weeks, your doctor may need to adjust your treatment.

While taking Ropinirol Kern Pharma

Inform your doctor if you or your family/caregiver notice that you are developing impulses or urges to behave in ways that are unusual for you and that you cannot resist the impulse, urge, or temptation to carry out certain activities that could harm you or others. These are known as impulse control disorders and may include behaviors such as compulsive gambling, excessive eating or spending, abnormally high sex drive, or increased sexual thoughts or feelings. Your doctor may need to adjust or discontinue your treatment.

Smoking and Ropinirol Kern Pharma

Inform your doctor if you have started or stopped smoking while taking Ropinirol Kern Pharma. Your doctor may need to adjust your dose.

Use of Ropinirol Kern Pharma with other medicines

Inform your doctor or pharmacist if you are using or have recently used any other medicines, including those obtained without a prescription.

Remember to inform your doctor or pharmacist if you start taking a new medicine while on Ropinirol Kern Pharma.

Some medicines may affect the action of ropinirol or make it more likely that you will experience adverse effects. Ropinirol may also alter the way other medicines work.

These medicines include:

• the antidepressant fluvoxamine,
• medicines for mental disorders, such as sulpiride,
• hormone replacement therapy (also called HRT),
• metoclopramide, used to treat nausea and stomach acid,
• the antibiotics ciprofloxacin or enoxacin,
• any other medicine for Parkinson’s disease.

Inform your doctor if you are taking, or have recently taken, any of these medicines.

Use of Ropinirol Kern Pharma with food, drink, and alcohol

You may take Ropinirol Kern Pharma with or without food.

Alcoholic beverages are not recommended while taking ropinirol.

Pregnancy and breastfeeding

Consult your doctor or pharmacist before using any medicine.

The use of ropinirol during pregnancy is not recommended unless your doctor determines that the benefit to you outweighs any possible risk to the fetus. Ropinirol should not be used during breastfeeding, as milk production may be affected.

Inform your doctor immediately if you are pregnant, think you are pregnant, or plan to become pregnant. Your doctor will advise you on what to do if you are breastfeeding or plan to breastfeed. Your doctor may recommend that you stop treatment with ropinirol.

Driving and use of machines

Ropinirol may cause drowsiness and sudden episodes of falling asleep. If this occurs, you must not drive or engage in activities where reduced attention could put you or others at risk of death or serious injury (e.g., operating machinery) until these episodes and/or drowsiness have resolved.

Ropinirol may cause hallucinations (seeing, hearing, or feeling things that are not present). If this occurs, do not drive or use machinery.

Ropinirol Kern Pharma contains lactose and hydrogenated castor oil. If your doctor has informed you that you have an intolerance to certain sugars, consult with them before taking this medicine.

This medicine may cause stomach discomfort and diarrhea because it contains hydrogenated castor oil.

3. How to take Ropinirol Kern Pharma

Follow exactly the administration instructions for Ropinirol given by your doctor. Consult your doctor or pharmacist if you have any doubts.

Use in children and adolescents

Do not give Ropinirol Kern Pharma to children. Ropinirol is normally not prescribed to patients under 18 years of age.

You may have been prescribed only ropinirol for the treatment of your Parkinson's disease symptoms, or you may also have been prescribed another medicine called L-dopa (also known as levodopa). If you are taking L-dopa, you might experience some sudden uncontrolled movements when you start taking ropinirol. Consult your doctor if this occurs, as you may need to reduce your L-dopa dose.

What dose of Ropinirol Kern Pharma should you take?

It may take some time to determine the optimal ropinirol dose for you.

The usual starting dose of ropinirol prolonged-release tablets is 2 mg once daily during the first week. From there, your doctor may increase the dose to 4 mg of ropinirol prolonged-release tablets once daily during the second week of treatment. In elderly patients, the doctor may increase the dose more slowly. Afterwards, your doctor may adjust the dose until reaching the most appropriate dose for you. Some patients may take up to 24 mg of ropinirol prolonged-release tablets daily.

If you experience adverse effects at the beginning of treatment that you cannot tolerate, consult your doctor. Your doctor may advise you to switch to a lower dose of ropinirol film-coated tablets (immediate-release) which you will take three times daily.

Do not take more Ropinirol Kern Pharma tablets than your doctor has prescribed.

It may take several weeks before ropinirol starts to work.

How to take your dose of Ropinirol Kern Pharma

Take Ropinirol Kern Pharma once daily, at the same time each day.

Swallow the Ropinirol Kern Pharma tablets whole, with a glass of water.

DO NOT break, chew, or crush the prolonged-release tablets. Doing so may pose a risk of receiving too high a dose, because the medicine would be released into your body too quickly.

If switching from ropinirol film-coated tablets (immediate-release)

Your doctor will adjust your dose of ropinirol prolonged-release tablets based on the dose of ropinirol film-coated tablets (immediate-release) you are currently taking.

Take your ropinirol film-coated tablets (immediate-release) as usual the day before the switch. Then, take your ropinirol prolonged-release tablets the following morning, and do not take any further ropinirol film-coated tablets (immediate-release).

If you take more Ropinirol Kern Pharma than you should

If you have taken more ropinirol than you should, consult your doctor or go to the nearest hospital immediately, or call the Toxicology Information Service. Telephone: 91 562 04 20, indicating the medicine and the amount ingested. If possible, show the package to the medical staff.

A person who has taken an overdose of ropinirol may experience one or more of the following symptoms: nausea, vomiting, dizziness, somnolence, fatigue (mental or physical tiredness), feeling faint, hallucinations.

If you forget to take Ropinirol Kern Pharma

Do not take a double dose to make up for a missed dose.

If you have forgotten to take Ropinirol Kern Pharma for one or more days, consult your doctor for advice on how to restart treatment.

If you stop taking Ropinirol Kern Pharma

Do not stop treatment with Ropinirol Kern Pharma without first consulting your doctor.

Take Ropinirol Kern Pharma for as long as your doctor recommends. Do not discontinue treatment unless instructed by your doctor.

If you stop treatment with Ropinirol Kern Pharma abruptly, your Parkinson's disease symptoms may worsen rapidly.

If you need to discontinue treatment with Ropinirol Kern Pharma, your doctor will gradually reduce your dose.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible adverse effects

Like all medicines, ropinirol may cause adverse effects, although not everyone experiences them.

The adverse effects of Ropinirol Kern Pharma are most likely to occur at the beginning of treatment or when the dose is increased. These are generally mild and may become less bothersome over time. Inform your doctor if you are concerned about any adverse effects.

Very common adverse effects (may affect more than 1 in 10 patients):

• feeling faint,
• somnolence,
• nausea.

Common adverse effects (may affect up to 1 in 10 patients):

• hallucinations (seeing things that are not really there),
• vomiting,
• dizziness,
• heartburn,
• stomach pain,
• constipation,
• swelling of the legs, feet, or hands.

Uncommon adverse effects (may affect up to 1 in 100 patients):

• dizziness or fainting, especially when standing up suddenly (this is due to a drop in blood pressure),
• feeling very sleepy during the day (excessive somnolence),
• falling asleep suddenly without feeling sleepy beforehand (sudden sleep episodes),
• mental problems such as delirium (severe confusion), delusional thoughts (irrational ideas), or paranoia (irrational suspicions),
• hiccups.

Adverse effects with unknown frequency:

• after stopping or reducing treatment with Ropinirol Kern Pharma: depression, apathy, anxiety, fatigue, sweating, or pain (known as dopamine agonist withdrawal syndrome or DAWS),
• spontaneous penile erection.

Some patients may experience the following adverse effects:

• allergic reactions such as redness, skin inflammation with itching (urticaria), swelling of the face, lips, mouth, tongue, or throat, which may cause difficulty swallowing or breathing, rash, or intense itching,
• changes in liver function, which may be detected in blood tests,
• inability to resist the impulse, desire, or temptation to carry out an action that could be harmful to you or others, which may include:
  • Strong urge to gamble excessively despite serious personal or family consequences.
  • Altered or increased sexual interest and behavior causing significant concern to you or others, for example, increased sexual desire.
  • Uncontrollable excessive shopping or spending.
  • Appetite disorders (eating large amounts of food in a short period of time) or compulsive eating (eating more food than normal and more than necessary to satisfy hunger).

Inform your doctor if you have experienced any of these behaviors; they will discuss how to manage or reduce the symptoms.

If you are taking ropinirol with L-dopa

People who take ropinirol with L-dopa may develop other adverse effects after some time:

• very common adverse effects are sudden, uncontrolled movements,
• a common adverse effect is confusion.

Reporting of adverse effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if they are adverse effects not listed in this leaflet. You may also report them directly via the Spanish Pharmacovigilance System for Human Medicines at the website: www.notificaRAM.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.

If you consider any of the adverse effects you experience to be severe, or if you notice any adverse effect not mentioned in this leaflet, inform your doctor or pharmacist.

5. Storage of Ropinirol Kern Pharma

Keep this medicine out of the sight and reach of children.

Do not use Ropinirol Kern Pharma after the expiry date stated on the packaging and blister. The expiry date refers to the last day of the month indicated after EXP.

Do not store above 30 °C.

Keep in the original packaging to protect from moisture.

Medicines must not be disposed of via wastewater or household waste. Return any unused medicines and their containers to the SIGRE point at your pharmacy. If you are unsure, please ask your pharmacist how to dispose of medicines and containers you no longer need. This will help protect the environment.

6. Contents of the pack and other information

Composition of Ropinirol Kern Pharma 8 mg prolonged-release tablets

• The active substance is Ropinirol. Each prolonged-release tablet contains 8 mg of Ropinirol (as hydrochloride).
• The other components are:

Tablet core: hypromellose 2208, monohydrate lactose, anhydrous colloidal silica, carbomer 4,000-11,000 mPa.s, hydrogenated castor oil, magnesium stearate.

Coating: hypromellose 2910, titanium dioxide (E171), macrogol 400, iron oxide red (E172), iron oxide yellow (E172), iron oxide black (E172).

Appearance of the medicinal product and contents of the pack

Ropinirol Kern Pharma 8 mg prolonged-release tablets are brown-red, biconvex, and oval in shape.

The tablets are available in packs of 21, 28, 42, and 84 prolonged-release tablets in blisters (OPA/Al/PVC//Al).

Only certain pack sizes may be marketed.

Marketing Authorization Holder

Kern Pharma, S.L.

Venus, 72 - Pol. Ind. Colón II

08228 Terrassa - Barcelona

Spain

Manufacturer

KRKA, d.d., Novo mesto, Šmarješka cesta 6, Novo mesto, Slovenia

or

TAD Pharma GmbH, Heinz-Lohmann-Str. 5, 27472 Cuxhaven, Germany

Date of the most recent revision of this leaflet: May 2023

Detailed and up-to-date information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS): http://www.aemps.gob.es/